x
Visit our new Mobile Website next time you access NetDania with your mobile device

ATYR PHARMA INC. - COMMON STOCK

1.6099
02-13:34:24 GMT
+0.0199
+1.2516%
ISIN:N/A

Figures - ATYR PHARMA INC. - COMMON STOCK

Open
1.6100
Close
1.5900
Year Change
14.1773
Year % Change
+14.1773%
52 Week High
2.6999
52 Week Low
1.0801
Volume
5096
Inc. Vol
100

News - ATYR PHARMA INC. - COMMON STOCK

02-13:44 GMT
Chart of the Day: EverQuote - Online Insurance
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
What Every Investor Gets Wrong About AI (and Where the Real Profits Are)
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
The Reaction to the Fed News Suggests A Strategy for Investors
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
If You Invested $1000 in Tractor Supply a Decade Ago, This is How Much It'd Be Worth Now
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
If You Invested $1000 in Skechers a Decade Ago, This is How Much It'd Be Worth Now
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
PENN Entertainment (PENN) Reports Q1 Loss, Misses Revenue Estimates
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
Is a Surprise Coming for CBRE Group (CBRE) This Earnings Season?
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
Upbound Group (UPBD) Tops Q1 Earnings and Revenue Estimates
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
Sealed Air (SEE) Tops Q1 Earnings and Revenue Estimates
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
Avanos Medical (AVNS) Q1 Earnings Lag Estimates
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:44 GMT
Driven Brands Holdings Inc. (DRVN) Surpasses Q1 Earnings Estimates
Source: NASDAQ Stocks, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:39 GMT
Bitcoin Drives Growth And Community Regeneration In Emerging Markets
Source: Forbes World, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:35 GMT
US Senators Introduce Bill To Legalize Marijuana
Source: Forbes World, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:35 GMT
Testing Starfield’s Huge New Patch: The Good And The Bad
Source: Forbes World, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:34 GMT
Rayonier Q1 24 Earnings Conference Call At 10:00 AM ET
Source: NASDAQ US Markets, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:34 GMT
Sealed Air Q1 24 Earnings Conference Call At 10:00 AM ET
Source: NASDAQ US Markets, Symbol: ATYR PHARMA INC. - COMMON STOCK
02-13:34 GMT
Exelon Q1 24 Earnings Conference Call At 10:00 AM ET
Source: NASDAQ US Markets, Symbol: ATYR PHARMA INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
37991.70
22.33
0.06%
5034.45
6.1
0.12%
17396.32
23.58
0.14%
58411.00
-30
-0.05%
17987.99
22.61
0.13%
38041.41
192.69
0.51%
3104.82
-8.22
-0.26%
8172.74
49.97
0.62%
18248.62
652.71
3.71%
7573.02
12.25
0.16%
22648.20
43.35
0.19%
2287.24
-36.42
-1.57%
83.57
0.084
0.10%
1.06810
-0.0036
-0.34%
154.629
-1.097
-0.70%
1.24907
-0.00455
-0.36%
0.65234
-0.00062
-0.09%
1.37252
0.00003
0.00%
165.17200
-1.729
-1.04%
0.85516
0.00027
0.03%
193.13100
-2.089
-1.07%
0.91327
-0.0031
-0.34%
0.97548
-0.00661
-0.67%
0.59210
-0.00076
-0.13%
105.82600
0.195
0.18%
Top Gainers
Name
Last
+/-
%
2.89
2.78
2526.13%
2.94
1.57
114.60%
8.67
2.16
33.18%
4.78
1.08
29.02%
9.80
2.08
26.94%
1.16
0.20
20.82%
113.52
18.77
19.81%
0.57
0.08
16.33%
1.49
0.21
16.12%
13.30
1.82
15.85%
Top Losers
Name
Last
+/-
%
1.83
-1.43
-43.86%
39.50
-14.29
-26.57%
13.50
-4.75
-26.03%
0.05
-0.02
-23.16%
27.26
-6.70
-19.74%
1.74
-0.44
-20.05%
0.01
0.00
-19.19%
29.60
-7.12
-19.40%
0.10
-0.02
-18.71%
53.92
-12.12
-18.35%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy